InfoBionic Appoints Gene Cattarina to Board of Directors

Mr. Cattarina Brings 40+ Years of Leadership Experience in Healthcare IT and Medical Devices

News provided by

Aug 22, 2017, 08:00 ET

BOSTON, Aug. 22, 2017 /PRNewswire/ -- InfoBionic, a digital health company focused on creating superior solutions for outpatient cardiac arrhythmia monitoring, has announced the appointment of Gene Cattarina to its Board of Directors. Mr. Cattarina brings over 40 years of experience in numerous senior executive positions at companies in healthcare information systems, products, medical devices, and professional services, and will apply his veteran insights to help InfoBionic continue to scale up commercialization of its market-shifting MoMe® Kardia Software as a Service (SaaS) remote cardiac monitoring platform.

InfoBionic, a digital health company focused on creating superior solutions for outpatient cardiac arrhythmia monitoring, announced the appointment of Gene Cattarina to its Board of Directors. Mr. Cattarina brings over 40 years of experience in numerous senior executive positions at companies in healthcare information systems, products, medical devices, and professional services, and will apply his veteran insights to help InfoBionic continue to scale up commercialization.

Mr. Cattarina is CEO of SafeOp Surgical, Inc., a medical device company that has developed the FDA-approved EPAD™ system for simplified neurological monitoring in a wide array of surgical procedures where full monitoring may not be indicated, cost-effective, or feasible. Prior to SafeOp, Mr. Cattarina was president and CEO of Capsule Technologie, Inc., a leading global provider of medical device integration solutions that was acquired by Qualcomm, Inc. (NASDAQ: QCOM) in 2015. He has also held CEO positions at Impulse Monitoring Systems, Inc., now a part of NuVasive (NASDAQ: NUVA); LYNX Medical Systems, Inc., now a part of OptumInsight, Inc.; Landacorp, Inc.; and Medicode, Inc., also now a part of OptumInsight, Inc.

"For decades, Gene has been on the forefront of healthcare information technology and medical device innovation, and his track record of success speaks for itself," said Stuart Long, CEO of InfoBionic. "His experience, perspective, and counsel will no doubt be of great value to InfoBionic as we continue to scale our disruptive platform, work to expand our operations, and realize our vision to redefine the standard of care in ways that benefit healthcare providers, their practices, and the patients they serve."

"InfoBionic is challenging the status quo of traditional, complex processes for remote cardiac monitoring, offering innovative full disclosure technology in a game-changing business model," said Mr. Cattarina. "I look forward to working with InfoBionic's exceptional team, and to contributing to the future direction and growth of their transformative platform."

About InfoBionic
InfoBionic is a digital health company focused on creating superior patient monitoring solutions for chronic disease management with an initial market focus on cardiac arrhythmias. InfoBionic's lead product, MoMe® Kardia, is the only remote cardiac arrhythmia detection and monitoring system that replicates in-hospital telemetry data, right in the office, by giving physicians 24/7 on-demand access to full disclosure Holter, Event, and MCT data via a HIPAA-compliant portal app. For more information, visit www.infobionic.com.

Media Contact:
Carla Nieser
610.240.0400, ext. 108
[email protected]

SOURCE InfoBionic